Diclofenac sodium 3% in hyaluronic acid 2.5% gel significantly diminishes the actinic keratosis area and severity index

Schmitz, L., Gupta, G., Segert, M. H., Kost, R., Sternberg, J., Gambichler, T., Stockfleth, E. and Dirschka, T. (2018) Diclofenac sodium 3% in hyaluronic acid 2.5% gel significantly diminishes the actinic keratosis area and severity index. Skin Pharmacology and Physiology, 31(4), pp. 206-211. (doi: 10.1159/000488248) (PMID:29791916)

Full text not currently available from Enlighten.

Abstract

Background/Aims: Actinic keratosis area and severity index (AKASI) is a new assessment tool to quantify the severity of actinic damage on the head. Thus far, it has not been evaluated in monitoring the efficacy of field-directed topical treatments in actinic keratosis (AK) in routine clinical practice. Thus, the aim of this study was to determine treatment outcomes by using AKASI 3 months after the initiation of topical application of diclofenac sodium 3% in hyaluronic acid 2.5% gel (DFS) in patients with AKs on the head. Methods: We performed a retrospective analysis of patients with AKs who had AKASI scores prior to and after treatment with DFS. Results: Of the 24 patients included, 20 (83.3%) showed an improvement in AKASI, 2 (8.3%) a stable AKASI, and 2 (8.3%) a worsening of AKASI after a median (interquartile range) follow-up period of 91.5 days (89.8–104.3). The median AKASI reduction was 31.4% (16.7–59.1). The Wilcoxon test showed significant differences (p = 0.0008) between baseline and posttreatment AKASI values. Conclusions: AKASI is an easy-touse quantitative tool for assessing the treatment outcome of field-directed therapies. Field-directed therapies of AK should no longer be monitored by assessments based on lesion counts alone.

Item Type:Articles
Keywords:AKASI, actinic keratosis, diclofenac sodium 3% gel, modified AKASI, NMSC.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Gupta, Dr Girish
Authors: Schmitz, L., Gupta, G., Segert, M. H., Kost, R., Sternberg, J., Gambichler, T., Stockfleth, E., and Dirschka, T.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Skin Pharmacology and Physiology
Publisher:Karger
ISSN:1660-5527
ISSN (Online):1660-5535
Published Online:23 May 2018

University Staff: Request a correction | Enlighten Editors: Update this record